LIVE RADIO
new metal + rock
the future of alternative
new indie
 

News

News Flashes 02.24.21: Johnson & Johnson COVID-19 Vaccine, Reading & Leeds Festival, New Spider-Man Movie

[Top Left Clockwise: Photo via Marvel, Photo via Shutterstock, Photo via Reading Leeds Festival]

Today we have Johnson & Johnson’s COVID-19 vaccine, the return of the Reading & Leeds Festival, and a new Spider-Man movie.

FDA Says Johnson & Johnson Vaccine Is Safe

Photo via Shutterstock

Johnson & Johnson’s single dose COVID-19 vaccine was reviewed by the FDA and found to be safe and effective. In a large clinical trial it was found to prevent hospitalizations and deaths and has an 85% effectiveness even in severe cases. This will be the third vaccine to be authorized for use in the US and the first to be administered in a single dose.
 

Reading & Leeds Festival Returns

Photo via Reading Leeds Festival Twitter

Music lovers rejoice!! Today on social media the Reading and Leeds Festival announced they will be returning this summer. The announcement comes thanks to the recent news from the UK government that is set to end social distancing restrictions by June 21. If all goes as planned this could be the much needed and awaited return of music festivals. 

Spider-Man Is Coming Back to the Big Screen 

Photo via Marvel

After some confusion and jokes by the stars of Spider-Man, the actual title of the new movie has been revealed and it’s not Spider-Man: Phone Home, Spider-Man: Home-Wrecker, or Spider-Man: Home Slice. Spider-Man: No Way Home starring Tom Holland, Zendaya, and  Jacob Batalon will open in theaters December 2021. 

 
COOKIE NOTICE
We utilize cookie technology to collect data regarding the number of visits a person has made to our site. This data is stored in aggregate form and is in no way singled out in an individual file. This information allows us to know what pages/sites are of interest to our users and what pages/sites may be of less interest. See more
GET THE NEW IDOBI APP
Carry the best music in your pocket with idobi.